Neurim's Melatonin War With Mylan Fast-Tracked For Trial
Neurim Pharmaceuticals will be headed to trial against a rival drugmaker in October in a bid to pull generic versions of its insomnia medication off the market after a London judge...To view the full article, register now.
Already a subscriber? Click here to view full article